Site Map

Cancer Types

• Colorectal Cancer
• Lung Cancer
• Melanoma
• Skin Cancer

Drugs

• Vemurafenib in melanoma
• Xalkori in lung cancer

Types

• EGFR mutations in lung cancer
• BRAF in melanoma

Types

• EGFR Mutation
• KRAS Mutation
• ALK EML4 Mutation
• T790M Mutation
• VeriStrat Positive Lung Cancer
• Squamous Cell Lung Cancer
• Large Cell Carcinoma
• Small Cell Lung Cancer

Drugs

• Xalkori
• Crizotinib
• Afatinib
• EGFR Inhibitor

Tests Procedures

• EML4-ALK Tests
• EGFR Mutation Tests
• KRAS Mutation Tests
• VeriStrat Test

Trials

• Combination Trials
• bibw 2992 Trial
• ALK Trial
• Erlotinib Trial
• KRAS Lung Trial
• Phase II Study
• Lung Cancer Trial

Types

• Acral
• Uveal
• Mucosal
• Eye Cancer
• Skin Cancer
• BRAF Melanoma
• Lentiginous
• Subungual Melanomas

Drugs

• Yervoy
• Ipilimumab
• Zelboraf
• PLX4032
• Vemurafenib
• Gleevec
• Imatinib
• GSK2118436
• Dabrafenib

Tests Procedures

• BRAF
• V600E
• c-KIT
• GNAQ
• GNA11

Trials

• Ipilimumab Trial
• Brain Melanoma
• plx4032 trial
• BRAF Inhibitor
• BRAF Melanoma
• Imatinib Mesylate
• MEK Inhibitor